Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China
- PMID: 32857838
- PMCID: PMC7499510
- DOI: 10.1093/cid/ciaa1289
Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China
Abstract
The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015-2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.
Keywords: COVID-19; China; drug resistance; tuberculosis.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Tuberculosis Elimination in the Era of Coronavirus Disease 2019 (COVID-19): A Moving Target.Clin Infect Dis. 2022 Feb 11;74(3):509-510. doi: 10.1093/cid/ciaa1400. Clin Infect Dis. 2022. PMID: 32927477 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical